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controlling the expression of a putative permease
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Abstract
Background: Bacteria use transcriptional regulation to respond to environmental stresses. Specifically, exposure to
antibacterial drugs is deemed to be an atypical stress, and altering transcriptional regulation in response to such
stress can increase bacterial drug resistance. However, only a few transcription factors that regulate drug resistance
have been reported.
Results: In the present study, a GntR family transcription factor, encoded by the MSMEG_0535 (Ms0535) gene, was shown
to be an isoniazid (INH) resistance regulator in Mycobacterium smegmatis. When the Ms0535 gene was overexpressed,
cells showed a significant increase in INH resistance. First, the interaction between Ms0535 and its own promoter was
determined, and a conserved 26-bp palindromic DNA binding motif was identified using electrophoretic mobility shift
and DNaseI footprinting assays. Second, quantitative reverse transcription-PCR assays showed that Ms0535 acted as a
transcriptional activator, and positively regulated its own expression, as well as that of a permease encoded by
the MSMEG_0534 (Ms0534) gene. Similar to the case for the Ms0535 gene, a recombinant Ms0534-overexpressing
strain also exhibited increased INH resistance compared with the wild-type strain. Furthermore, we showed that
Ms0535 and Ms0534 deletion strains were more sensitive to INH than the wild-type strain. Interestingly, overexpressing
Ms0534 in the Ms0535 deletion strain enhanced its INH resistance. In contrast, the Ms0534 deletion strain was still sensitive
to INH even when Ms0535 was overexpressed. These findings suggest that Ms0534 is an effector protein that affects INH
resistance in M. smegmatis.
Conclusions: In summary, the GntR transcriptional regulator Ms0535 positively regulates INH resistance by
transcriptionally regulating the expression of the Ms0534 permease in M. smegmatis. These results improve
our understanding of the role of transcriptional regulation in INH drug resistance in mycobacteria.
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Background
Transcriptional regulation plays an important role in the
bacterial response to environmental stresses. Antibacterial
drugs are deemed to be atypical stressors, and changes in
transcriptional regulation can increase bacterial drug re-
sistance [1]. When exposed to such drugs, bacteria can
undergo complex responses, such as inactivating the tar-
gets, modifying the drugs, or expressing drug efflux sys-
tem proteins. Today, more than 20 transporter proteins
have been found to be associated with tetracycline efflux
systems [2]. Bacterial drug efflux pumps can efflux drugs
out of the cell, thereby lowering the drug concentration,
and up-regulating the expression of membrane drug efflux
pump proteins is the key mechanism by which bacteria in-
crease their drug resistance [3]. Five different categories of
drug transporters have been investigated: the ATP-binding
cassette (ABC) superfamily, the major facilitator super-
family (MFS), the multidrug and toxic compound extru-
sion (MATE) family, the small multidrug resistance (SMR)
family, and the resistance/nodulation/cell division (RND)
family [2].
MFS members are widespread, and they play important
roles in drug transport in organisms ranging from bacteria
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to humans [4]. The MFS was first found to transport glu-
cide, and, subsequently, drugs, phosphates, and oligosac-
charides [5]. An MFS permease is directly involved in the
bacterial drug efflux process [4]. Some bacterial transcrip-
tion regulatory proteins, such as Bacillus subtilis BmrR,
Staphylococcus aureus QacR, and Mycobacterium smeg-
matis LfrA, can regulate the expression of drug trans-
porters by acting either as transcriptional repressors or
activators of drug efflux genes [6–8]. However, our
knowledge of the transcriptional factors that regulate
anti-mycobacterial drug transporter-related genes is
still limited.
Mycobacterium smegmatis is a relatively fast-growing
and non-pathogenic mycobacterium, and it is frequently
used as a model organism to study the gene regulatory
mechanisms of M. tuberculosis [9, 10]. Notably, the gen-
ome of M. tuberculosis encodes at least 20 possible drug
efflux transporters [11]. Some of these transporter pro-
teins play a role in mycobacterial resistance to isoniazid
(INH), rifampicin (RIF), tetracycline, and other antibi-
otics [12–14]. In comparison with M. tuberculosis, M.
smegmatis has more drug efflux systems and transcrip-
tion factors; however, the mechanisms by which they are
regulated are largely unknown.
GntR family transcription factors, which are named
after a gluconate operon repressor in B. subtilis, are
widely distributed in bacteria [15, 16]. GntR members
contain a conserved N-terminal helix-turn-helix (HTH)
domain for DNA-binding and diverse C-terminal do-
mains [15]. The variable C-terminal domain provides
the basis for their classification into six subfamilies. Ex-
cept for Ms2173, a global Cu2+-responsive transcription
factor [17], members of the GntR/FadR subfamily have
been rarely reported in M. smegmatis. GntR family
members usually function as transcriptional repressors,
although some of them are transcriptional activators.
For instance, Serratia marcescens PigT [18], Entero-
coccus faecalis CitO [19], FadR [20], and McbR/YncC
[21] from Escherichia coli, NorG from Staphylococcus
aureus [22, 23], HpxS from Klebsiella pneumoniae [24],
and B. subtilis GabR [25] were shown to act as transcrip-
tional activators or repressor/activators.
In this study, we have shown that a GntR family tran-
scription factor, encoded by the Ms0535 gene, plays a
role in M. smegmatis drug resistance. Ms0535 specific-
ally bound its own promoter by recognizing a 26-bp
palindromic sequence motif that is separated by four nu-
cleotides. It regulates M. smegmatis INH resistance by
functioning as a transcriptional activator that regulates
the expression of the MFS permease gene Ms0534,
which is located in the same operon. This is the first
study to clarify the regulatory mechanism of the tran-
scriptional factor Ms0535 and its role in M. smegmatis
INH resistance.
Results
Mycobacterium smegmatis Ms0535 potentially contributes
to mycobacterial INH resistance
To identify potential transcription factors that regulate drug
resistance in M. smegmatis, we screened a transcriptional
regulator library by spotting these recombinant strains onto
plates containing INH (20 μg/mL). About 500 predicted
regulatory genes in the genome of the M. smegmatis
strain mc2155 (Genbank accession number CP000480)
were cloned into pMV261, and the recombinant plasmids
were transformed into M. smegmatis. Transformant strains
were spotted onto 7H10 medium containing 20 μg/mL
INH. The recombinant plasmids were isolated from the
INH-resistant M. smegmatis transformants, which en-
abled the positive regulator genes to be characterized
by sequencing.
A hypothetical transcriptional factor, encoded by the
Ms0535 gene, was isolated as a potential contributor to
INH resistance in M. smegmatis. As shown in Fig. 1a,
the mycobacterial strain transformed with pMV261-
Ms0535, which overexpresses Ms0535, was more re-
sistant to 20 μg/mL INH than the wild-type strain
transformed with the empty pMV261 vector (Fig. 1a).
The evidence suggested that Ms0535 is potentially in-
volved in regulating INH drug resistance in M. smegmatis.
A sequence analysis revealed that Ms0535 contains an N-
terminal winged HTH DNA-binding domain and a typical
all-helical C-terminal domain belonging to the FadR sub-
family [26]. The absence of the first α-helix indicates that
Ms0535 encodes a VanR-like regulator (Fig. 1b).
Ms0535 binds its own promoter
Several assays were performed to detect the DNA binding
activity of Ms0535. First, a bacterial one-hybrid system
[27] was used to detected protein-DNA interactions. The
promoter region (500 bp upstream) of Ms0535, Ms0535p,
and the unrelated promoter Ms0540p (500 bp upstream of
Ms0540) were cloned into the reporter vector pBXcmT
[27] and co-transformed into reporter strains with pTRG-
Ms0535. Co-transformants of both the positive control
pTRG-Rv3133c/pBX-Rv2031p, as well as pTRG-Ms0535/
pBX-Ms0535p, grew very well in the screening medium
(Fig. 2a). In contrast, no growth was observed for the self-
activated controls and the negative control (Fig. 2a). Thus,
Ms0535 can bind to its promoter, Ms0535p.
Second, electrophoretic mobility shift assays (EMSAs)
were conducted to show that Ms0535 binds to Ms0535p
in vitro. As shown in Fig. 2b, 0.03 nM of the Ms0535p
DNA substrate was co-incubated with different amounts
(1–4 μM) of his-tagged Ms0535 protein, and clear band
shifts were observed, indicating the formation of DNA-
protein complexes (Fig. 2b, lanes 1–4). In contrast, Ms0535
did not bind to the Ms0540p negative control promoter
(Fig. 2b, lanes 5–8). Additionally, a competition assay was
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Fig. 1 The effect of Ms0535 on the drug resistance of M. smegmatis and a sequence alignment of the Ms0535 C-terminal domain. (a) Isoniazid
(INH)-resistance of the M. smegmatis (Msm) strain overexpressing Ms0535. Msm/pMV261 and Msm/pMV261-Ms0535 were grown on medium
containing 30 μg/mL kanamycin for 36 h. Then, different concentrations of freshly grown bacteria were streaked onto 7H10 plates containing
kanamycin (30 μg/mL) and INH (20 μg/mL). The control plate did not contain INH. (b) Analysis of the structural characteristics of Ms0535. The
Ms0535 amino acid sequence was analyzed using the online tool SWISS-MODEL. The N-terminal region of Ms0535 contains a winged helix-turn-helix
GntR DNA-binding domain, while its C-terminus contains a domain that is similar to that of the FCD family. Amino acid residues present in α-helices
are highlighted in gray, and spaces in the consensus sequence denote insertions within the alignment
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performed. Unlabeled Ms0535p and Ms0540p pro-
moters were used to compete with labeled Ms0535p,
and Ms0535p, but not Ms0540p, could competitively
inhibit the binding of Ms0535 to the labeled Ms0535p
promoter (Fig. 2c).
These findings strongly suggest that Ms0535 can specif-
ically bind to its own promoter, Ms0535p.
Ms0535 recognizes a palindromic sequence motif
To identify the DNA-binding site for Ms0535, a DNase I
footprinting assay was performed as described previously
[28]. The results showed that Ms0535 protected the se-
quence 5′-CCTTGCATGCATTCTTGCATGCAAGG-3′
in the Ms0535p promoter (Fig. 3a). The protected DNA re-
gion extended from positions −19 to −44 (assuming the
Ms0535 start codon to be +1) in the coding strand (Fig. 3b).
In this region, a palindromic motif formed by two IRs
(5′-CCTTGCATGCA-3′), which are separated by 4 nt,
was found (Fig. 3b). To detect binding between Ms0535
and the binding motif, short oligonucleotides were
synthesized, and EMSAs were conducted. In the experi-
ments, the wild-type motif and three mutants were in-
cluded (Fig. 3c). The results showed that Ms0535 bound
the wild-type Ms0535p0 substrate, resulting in shifted
bands (Fig. 3c, lanes 1–4). In addition, Ms0535 also bound
to Ms0535p1 and Ms0535p2, in which one IR was mutated
(Fig. 3c, lanes 5–8 and 9–12, respectively). In contrast,
Ms0535 did not bind the Ms0535p7 fragment, in which
both IRs were mutated (Fig. 3c, lanes 13–16). Interestingly,
when Ms0535 bound to Ms0535p1 and Ms0535p2, the sin-
gle IR mutants, only one shifted band was observed (Fig. 3c,
lanes 5–8 and 9–12, respectively), suggesting that Ms0535
may bind the promoter in two steps.
In conclusion, these results indicate that Ms0535 rec-
ognizes a 26-bp palindromic sequence motif.
The Ms0535 and Ms0534 genes reside in an Ms0534-0535
operon
Because Ms0535 binds to a 26-bp sequence motif in the
upstream region of its own promoter, we created a system
Fig. 2 Ms0535 specifically binds to its own promoter. (a) Bacterial one-hybrid assays. Promoters of the Ms0535 and Ms0540 genes were cloned
into the pBXcmT vector, and the Ms0535 gene was cloned into the pTRG vector. A pair of pBXcmT/pTRG plasmids was co-transformed into the
reporter strain, and then its growth was tested together with the self-activation controls on a selective medium. Co-transformants containing the
pBX-Rv2031/pTRG-Rv3133 plasmids [26] served as positive controls (CK+), and co-transformants containing the empty vectors pBXcmT and pTRG
served as negative controls (CK−). (b) Electrophoretic mobility shift assays (EMSAs). The Ms0535p (lanes 1–4) and Ms0540p (lanes 5–8) DNA substrates were
co-incubated with various amounts of the Ms0535 protein. The free DNA substrate and DNA-protein complexes are indicated. (c) EMSAs for the specific
binding of Ms0535 to its own promoter. Then, 0.05 nM of fluorescein isothiocyanate-labeled Ms0535 promoter DNA substrate was co-incubated with the
Ms0535 protein in the absence (lanes 1–5) or presence of non-labeled Ms0535p (0.25-1 nM) (lanes 6–8) or non-labeled Ms0540p (0.25-1 nM) (lanes 9–11).
Unlabeled Ms0535 and unlabeled Ms0540 promoter DNA substrates were used to compete with the labeled Ms0535 promoter DNA. The Ms0535 promoter,
but not the Ms0540 promoter, inhibited the binding of Ms0535 to the labeled Ms0535 promoter DNA substrate
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to locate the putative promoter and to detect the operator
region of Ms0535 (Fig. 3d). A genomic location analysis
suggested that Ms0535 shares the same upstream DNA
region with the MFS permease Ms0534. Subsequent re-
verse transcription-PCR (RT-PCR) assays showed that the
two genes were co-transcribed (Fig. 4). The cDNA used in
this experiment was reverse transcribed by a reverse
primer that was complementary to a region within the
Ms0535 gene. DNA fragments encompassing the Ms0534
and MS0535 genes, as well as the region between the genes,
can be amplified from the cDNA template. An mRNA tem-
plate and the amplification of an unrelated DNA fragment
encompassing the Ms0540 gene were used as negative con-
trols. This result suggests that the Ms0534 and Ms0535
genes are co-transcripted and reside in an Ms0534-Ms0535
operon in M. smegmatis.
Fig. 3 DNA-binding motif assays for Ms0535. (a) Dye primer sequencing based on a DNase I footprinting assay. The Ms0535 promoter DNA was
digested with DNaseI in the presence of increasing amounts of Ms0535. The protected regions are indicated by a black frame. (b) Sequence and
structural characteristics of the protected Ms0535 promoter region. The regions protected by Ms0535 are underlined. The binding motif is a 26-bp
sequence containing invert repeats (IRs) with a 4-bp spacer. The translational start codon of Ms0535 is indicated in bold. (c) Electrophoretic
mobility shift assays of the DNA-binding activity of Ms0535 towards DNA substrates with (lanes 1–4) or without (lanes 13–16) the IR sequences. The DNA
substrates were individually incubated with 0–4 μM of the Ms0535 protein. (d) Analysis of the domain structure of Ms0535 and the genomic location of
its DNA binding motif. The Ms0535 gene encodes a typical GntR regulator, and it shares a common upstream promoter region with the major facilitator
superfamily permease Ms0534. The distance between the motif and the coding sequence of Ms0535 is 18 bp
Hu et al. BMC Microbiology  (2015) 15:214 Page 5 of 11
Ms0535 positively regulates its own expression and the
expression of Ms0534
To characterize the biological function of Ms0535, we con-
structed a M. smegmatis Ms0535 knockout strain using a
gene replacement strategy (Additional file 1: Figure S1).
Subsequently, the expression of the adjacent gene, Ms0534,
in both the wild-type and Ms0535 deletion strains was
compared by quantitative RT-PCR (qRT-PCR) assays. As
shown in Fig. 5a, the expression of Ms0534 was signifi-
cantly down-regulated in the Ms0535 knockout strain com-
pared with that in the wild-type strain. In contrast, the
expression of the negative control gene Ms0540, whose
promoter does not contain a conserved binding motif, did
not show any obvious changes. This finding suggested that
Ms0535 could function as a positive regulator. Consistent
with this view, when Ms0535 was overexpressed (by ap-
proximately six-fold), the expression of Ms0534 was signifi-
cantly up-regulated (Fig. 5b). These results indicate that
Ms0535 can function as a positive regulator of Ms0535/
Ms0534 in M. smegmatis.
As we proved, overexpressing Ms0535 can increase the
INH resistance of M. smegmatis. To determine whether
INH can affect the expression of Ms0535, qRT-PCR ex-
periments were performed on the wild-type strain after
cultivation in the presence or absence of INH for 6 h
(Fig. 5c). Cultivation in the presence of 10 μg/mL INH did
not alter the expression of the Ms0534 and Ms0535 genes.
However, in the presence of 30 μg/mL INH, the expres-
sion of Ms0535 increased by 1.4-fold relative to bacteria
grown in the absence of INH, while Ms0534 expression
increased 1.6-fold. Since these differences in expression
were not very significant, we concluded that these two
genes are not INH-responsive genes, although overexpres-
sion of either Ms0535 or Ms0534 increases INH resistance
(see below).
Ms0535 regulates M. smegmatis antibiotic resistance via
the putative permease Ms0534
Ms0534 has been predicted to encode a permease that is
possibly involved in drug export. Moreover, using the
sequence of the Ms0535 DNA binding motif as a BLAST
query, no more binding site was found in the M. smeg-
matis genome, except for the Ms0535p promoter. Taken
together, we hypothesized that Ms0534 should be the
effector protein that confers INH resistance in Ms0535-
overexpressing strains. To test this hypothesis, Ms0535
(Additional file 1: Figure S1) and Ms0534 knockout
strains (Additional file 2: Figure S2), together with mul-
tiple complementary strains, were constructed.
We first determined the growth curves of the wild-type
and Ms0534/Ms0535-overexpressing strains. As shown in
Fig. 6a, the Ms0535-overexpressing strain grew much bet-
ter than the wild-type strain in 7H9 medium containing
10 μg/ml INH (Fig. 6a, left panel), but their growth was
Fig. 4 Assays for Ms0534-Ms0535 co-transcription by reverse transcription-PCR. (a) The schematic operon structure of Ms0534-Ms0535. Primers designed for
the assays are indicated by black arrows; F1 primers are complementary to the sequences of the two adjacent genes. (b) Reverse transcription-PCR assays
for Ms0534-Ms0535 co-transcription. In this assay, the resulting cDNA was transcribed by the F3 reverse primer. For the F1 fragment, mRNA (DNA-free) was
used as a negative control (lane 1). In lane 2, a 189-bp reverse transcription-PCR product indicates the co-transcription of Ms0534-Ms0535. The 146-bp F2
and 100-bp F3 extension products are shown in lanes 2 and 3. The negative result in lane 5 reveals that the F4 fragment cannot be amplified from the
cDNA template. The PCR procedure was as follows: the reactions underwent 35 cycles of denaturation at 95 °C for 30 s, annealing at 60 °C for 30 s, and
extension at 72 °C for 30 s
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similar in the absence of INH (Additional file 3: Figure
S3A, left panel). Comparably, the Ms0534-overexpressing
strain grew much better than the wild-type strain in the
presence (Fig. 6a, right panel), but not in the absence of
INH (Additional file 3: Figure S3A, right panel).
Furthermore, the growth curves of the wild-type, Ms0535
deletion, and complemented strains were determined. As
shown in Fig. 6b, both the Ms0535 (left panel) and Ms0534
deletion strains (right panel) were more sensitive to INH,
and their sensitivity could be complemented by inducing
the expression of Ms0535 or Ms0534, respectively, using
the pMindD system [17]. All these strains grew similarly in
the absence of INH (Additional file 3: Figure S3B).
In addition, the Ms0535 deletion strain was comple-
mented with the Ms0534 gene, and the Ms0534 deletion
strain was complemented with the Ms0535 gene, and
the growth curves of these strains were determined with
(Fig. 6c) or without (Additional file 3: Figure S3C) INH.
As shown in Fig. 6c, complementation with the Ms0534
gene improved the growth of the Ms0535 deletion strain
(Fig. 6c, left). However, complementation with the Ms0535
gene did not improve the growth of the Ms0534 deletion
strain (Fig. 6c, right).
These results support our hypothesis, and they indicate
that Ms0535 regulates INH resistance through Ms0534,
and Ms0534 is the effector protein that confers INH re-
sistance to the Ms0535-overexpressing strain.
Discussion
In recent decades, bacteria, especially some important path-
ogens such as M. tuberculosis, exhibiting drug and multi-
drug resistance (MDR) have become a major health issue
worldwide [29]. In the current study, we showed that a
GntR family transcription factor, encoded by the Ms0535
gene, activates the expression of the efflux pump protein
Ms0534, an MFS permease, thereby affecting the drug re-
sistance of M. smegmatis.
Drug efflux pump proteins play an important role in
bacterial drug resistance [30, 31]. Several transcription
factors involved in the regulation of these proteins have
been characterized [6–8]. Ms2173, a global Cu2+-respon-
sive GntR family transcription factor, was found to be
involved in regulating the expression of 37 membrane
transport genes, and it was shown to negatively affect
mycobacterial drug resistance [18]. GntR family tran-
scription factors, which can regulate MDR, antibiotic
biosynthesis, cell permeability, and virulence [5, 32],
are widely distributed in bacteria [26]; GntR is named
after a repressor of the B. subtilis gluconate operon [5].
The family members usually function as transcriptional
repressors, although there are also reports of GntR
activators, such as S. marcescens PigT [18], E. faecalis
CitO [19], and B. subtilis GabR [25]. The genomes of
mycobacteria contain a large number of GntR family
transcription factors [11], although little is known about the
function of the other members of this family. In this study,
we isolated and characterized the GntR/FadR subfamily
transcriptional factor Ms0535, which acts as an activator
and positively affects drug resistance in M. smegmatis.
DNaseI footprinting assays and EMSAs confirmed that
Ms0535 specifically recognized a 26-bp palindromic se-
quence motif, which was separated by 4 nt (Fig. 3a).
The MFS is one of the major types of bacterial drug
efflux pumps, and it plays an important role in bacterial
Fig. 5 Quantitative real time-PCR assays. Gene expressions were
determined in the M. smegmatis Ms0535 deletion strain (a), in the
Ms0535-overexpressing strain (b), and in wild type strain with or
without isoniazid (c). The relative expression levels of the genes
were normalized using the sigA gene as an invariant transcript. An
unrelated promoter of the Ms0540 gene was used as a negative
control. Data were analyzed using the 2−ΔΔCt method as described
in the Methods. P-values of the relative expression data were calculated
by an unpaired two-tailed Student’s t-test
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drug efflux [4, 5]. The current study showed that most
of the mycobacterial drug efflux pumps belong to the
MFS. This confirmed that the transporters of the MFS
play an important role in mycobacterial drug resistance
[33]. LfrA is a transporter protein that belongs to the
MFS, and it is mainly involved in the efflux of EB and
acriflavine in bacteria. It is the first drug efflux pump
been discovered in M. tuberculosis [8]. Ms0534 is a perme-
ase that belongs to the MFS. It is located in the same op-
eron as the GntR family transcriptional factor Ms0535. In
this study, we found that Ms0535 activates the expression
of Ms0534 (Fig. 5a). An interesting finding from the
present work was the determination that both Ms0535-
and Ms0534-overexpressing mycobacterial strains exhib-
ited higher levels of INH resistance than the wild-type
strain (Fig. 6a left and right panels, respectively). Con-
versely, the Ms0535 and Ms0534 deletion strains were
more sensitive to INH than the wild-type strain (Fig. 6a
right panel; Fig. 6b, left panel). Furthermore, we found that
overexpressing Ms0534 in the Ms0535 deletion strain en-
hanced mycobacterial INH resistance (Fig. 6b, middle
panel). However, overexpressing Ms0535 in the Ms0534
Fig. 6 Determinations of growth curves of M. smegmatis strains. Mycobacterial strains were grown in 7H9 medium in the presence of 10 μg/ml
isoniazid, and growth curves were determined. (a) Left: the wild-type (WT/pMV261) and Ms0535-overexpressing (WT/pMV261-Ms0535) strains; Right:
the WT (WT/pMV261) and Ms0534-overexpressing (WT/pMV261-Ms0534) strains. To avoid potential side effects, the empty pMV261vector was included
in the WT strain. (b) Left: the WT (WT/pMindD), Ms0535 deletion (ΔMs0535/pMindD), and ΔMs0535 complemented (ΔMs0535/pMindD-Ms0535) strains;
Right: the WT (WT/pMindD), Ms0534 deletion (ΔMs0534/pMindD), and ΔMs0534 complemented (ΔMs0534/pMindD-Ms0534) strains. To avoid potential
side effects, the empty pMindD vector was included in the WT and Ms0534/Ms0535 deletion strains. (c) Left: the Ms0535 deletion (ΔMs0535/pMV261)
strain and the ΔMs0535 strain complemented with Ms0534 (ΔMs0535/pMV261-Ms0534); Right: the Ms0534 deletion strain (ΔMs0534/pMV261) and the
ΔMs0534 strain complemented with Ms0535 (ΔMs0534/pMV261-Ms0535). To avoid potential side effects, the empty pMV261 vector was included in the
Ms0534/Ms0535 deleted strains. Error bars represent the standard deviation of three biological replicates
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deletion strain did not affect INH resistance (Fig. 6b, right
panel). This suggests that Ms0535 acts as a transcriptional
activator that regulates the expression of the drug efflux
pump protein Ms0534, which positively regulates the drug
resistance of M. smegmatis.
It is noteworthy that although the complementation
strains grew better than the deletion strains under INH
stress, their resistance to INH are still far from the wild-
type control (Fig. 6b). One probable reason for this
result is that the corresponding promoter activities are
different in the pMindD vector and the M. smegmatis
genome. Another possibility is that induce of hyg gene
may cause polar effect in gene expression. Using a scarless
gene deletion may avoid this effect by removing antibiotic
resistance genes with phage infection [34].
As is well known, INH is active exclusively against
mycobacteria, but pathogenic M. tuberculosis and non-
pathogenic M. smegmatis display greatly different sensi-
tivities to INH. Compared with its activity against M.
tuberculosis, INH is 100 times less active against M.
smegmatis [35]. Additionally, genomic variations between
the two species may also be responsible for this difference.
The M. smegmatis genome encodes more than 500 poten-
tial regulatory factors; however, only 214 regulatory factors
are encoded by the M. tuberculosis genome. Ms0535 is a
GntR family transcription factor encoded by the M. smeg-
matis genome, while absent in M. tuberculosis. Further-
more, its target Ms0534, a putative permease, is absent in
M. tuberculosis as well. According to our results, these two
genes may contribute the drug resistance of M. smegmatis
and this partially explain the difference in INH resistance
between the two mycobacterial species.
Studies have shown that MFS proteins can transport
molecules such as drugs, glucide, and phosphate [5]. Con-
sistently, we showed that overexpression of the transcrip-
tion factor Ms0535 and the MFS permease Ms0534 affects
the INH resistance of M. smegmatis. Additionally, no po-
tential Ms0535 target genes were identified by searching
the M. smegmatis with the sequence of the Ms0535 DNA
binding motif. This suggests that Ms0534 may transport
INH, and that Ms0535 specifically regulates this process.
Conclusions
In the present study, a GntR family, VanR-like transcrip-
tional factor, Ms0535, was shown to be a transcription ac-
tivator and to positively regulate INH resistance of M.
smegmatis. Ms0535 specifically recognized a 26-bp palin-
dromic sequence motif separated by a 4-nt spacer, and it
activated its own expression, as well as that of the Ms0534
efflux pump gene in the same operon. Our findings estab-
lish Ms0535 as a novel GntR family activator in mycobac-
teria, and they significantly enhance our understanding of
the regulatory mechanism of bacterial drug resistance.
Methods
Strains, enzymes, plasmids and reagents
E. coli BL21 cells and pET28a vector were purchased from
Novagen (Darmstadt, Germany). pBT, pTRG vectors and E.
coli XR host strains were purchased from Stratagene (La
Jolla, CA, USA) (Additional file 4: Table S1). Restriction en-
zymes, T4 ligase, Modification enzymes, Pyrobest DNA
polymerase, dNTPs and all antibiotics were obtained from
TaKaRa Biotech (Shiga, Japan). The reagents for one-hybrid
assay were purchased from Stratagene. Polymerase Chain
Reaction (PCR) primers were synthesized by Invitrogen
(Carlsbad, CA, USA) (Additional file 4: Table S2).
The screening of isoniazid related transcriptional
regulators
Over 500 transcriptional regulator genes were amplified
from M. smegmatis genomic DNA. The gene fragments
were mixed as a pool and cloned into pMV261 vector [36]
to construct the regulatory genes overexpression plasmids
library. The plasmids library were electrophoretic trans-
ferred into M. smegmatis mc2 155, and the strains were
screened on 7H10 plates containing 20 μg/mL INH. As a
result, those having increased INH resistance or decreased
INH susceptibilities were identified as primary candidates.
To avoid random mutations that may contribute to INH
resistance, plasmid were extracted from each of the primary
candidates, and transformed into the wild type M.
smegmatis and assayed thrice in a similar way. In final,
the increased INH resistance is sufficient to attribute
to the overexpression of the corresponding transcrip-
tional regulator.
Bacterial one-hybrid assay
Bacterial One-Hybrid assays were carried out as described
previously [27]. Ms0535 was cloned into the pTRG vector
(Stratagene). Promoters (500 bp upsteam of the open read-
ing frame) of the M. smegmatis genes were amplified using
appropriate primers (Additional file 4: Table S2) and cloned
into the pBXcmT vector. The selective plate contains
20 mM 3-AT (3-amino-1,2,4-triazole), 16 μg/ml strepto-
mycin, 15 μg/ml tetracycline, 34 μg/ml chloramphenicol
and 30 μg/ml kanamycin. A co-transformant containing
pBX-Rv2031/pTRG-Rv3133 plasmids was served as positive
control (CK+) and a co-transformant containing empty
vector pBX and pTRG was served as negative control
(CK-). A co-transformant containing pTRG-Ms0535/
pBXcmT plasmids and pTRG/pBX-Ms0535p plasmids
were served as self-activated controls. The plates were
incubated at 30 °C for 3–4 days.
Cloning, expression and protein purification
Cloning, expression and protein purification were per-
formed as previously described [37]. M. smegmatis
mc2 155 genes were amplified using specific primers
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(Additional file 4: Table S2). Ms0535 was cloned into
the pET28a vector to produce recombinant vectors
(Additional file 4: Table S1).
Electrophoretic mobility shift assay (EMSA)
DNA fragments for the DNA-binding activity assays
were amplified by PCR from M. smegmatis genomic
DNA using their primers labeled with Fluorescein Iso-
thiocyanateor (FITC) or directly synthesized (Additional
file 4: Table S2). The EMSA assays were conducted as
previously described [37].
DNase I footprinting assay
The 300 bp promoter region of the Ms0535 gene
(Additional file 4: Table S1) was amplified by PCR
using appropriate primers labeled with Fluorescein Iso-
thiocyanate (FITC) (Additional file 4: Table S2). The
amplified products were purified with BioFlux PCR
DNA Purification kit (BioFlux) and then subjected to
similar binding reaction as in EMSA. DNaseI foot-
printing was performed using the method of dye pri-
mer sequencing [38, 39].
Recombinant strains
Knockout of the Ms0535 and Ms0534 gene in M. smegma-
tis was performed as described previously [38, 40]. Deletion
of Ms0535 and Ms0534 were further verified by Southern
blotting [39]. Primers used in the assays were provided in
Additional file 4: Table S1.
Ms0534 and Ms0535 genes were amplified from M.
smegmatis genomic DNA by their respective primers
(Additional file 4: Table S2). To overproduce in M. smeg-
matis, Ms0534 gene was inserted downstream of the hsp60
promotor of pMV261 [36]. And the Ms0534 and Ms0535
genes were cloned into a pMind vector [41] for comple-
menting in knockout strains. The recombinant plasmids
were electroporated into M. smegmatis mc2 155 and se-
lected on 7H10 medium containing 30 mg/mL kanamycin.
Quantitative real time PCR (qRT-PCR)
qRT-PCR were performed as described previously [38].
Isolation of mRNA and cDNA preparation of wild type
strains, deletion mutants and overexpression M. smeg-
matis strains were performed and real-time PCR analysis
was subsequently carried out according to previously de-
scribed procedures [37]. Each PCR reaction (20 μl) con-
tained 2 μl of 2 × SYBR Green Master Mix Reagent
(Applied Biosystems), 1.0 μl of cDNA samples and 200 nM
gene-specific primers (Additional file 4: Table S3). Gene
expression levels were normalized to the levels of sigA
rRNA gene transcripts and relative expression changes
were calculated using the 2-ΔΔCt method [38, 42].
Determination of mycobacterial growth curves
Growth patterns of the wild-type (Msm) mycobacterial
strain, Ms0535-deleted mutant (Msm/Ms0535::hyg),
Ms0534-deleted mutant (Msm/Ms0534::hyg), the overex-
pression (Msm/pMV261-Ms0535, Msm/pMV261-Ms0534)
mycobacterial strains and complemented strains (Msm/
pMindD-Ms0535, Msm/pMindD-Ms0534) were deter-
mined according to previously described [9].
Availability of supporting data
The data sets supporting the results of this article are in-
cluded within the article and its additional files.
Additional files
Additional file 1: Figure S1. Construction of the M. smegmatis Ms0535
knockout strain and Southern blotting assay. (A) Schematic of the
recombination strategy for the deletion of the Ms0535 gene from the
M. smegmatis genome. (B) A map of the recombinant vector pMind-Ms0535
containing the upstream and downstream sequences of Ms0535 and the
gene that confers resistance against hygromycin. (C) Schematic of the DNA
fragments of the wild-type and ΔMs0535 knockout strains treated with the
restriction enzyme SmaI. The probe is indicated with a black bar. (D) Southern
blot assays. A 300-bp probe corresponding to the sequences of the Ms0535
upstream genomic fragment of M. smegmatis was obtained by PCR and
labeled with digoxigenin dUTP (Roche, Mannheim Germany). The probe
was used to detect changes in the size of the SmaI-digested genomic
fragment of M. smegmatis before and after recombination. (TIFF 942 kb)
Additional file 2: Figure S2. Construction of the M. smegmatis Ms0534
knockout strain and Southern blotting assays. (A) Schematic of the
recombination strategy for the deletion of the Ms0534 gene from the M.
smegmatis genome. (B) A map of the recombinant vector pMind-Ms0534
containing upstream and downstream sequences of Ms0534 and the
gene that confers resistance against hygromycin. (C) Schematic representation
of the DNA fragments of the wild-type and ΔMs0534 knockout strains treated
with the restriction enzyme NarI. The probe is indicated with a black bar. (D)
Southern blot assays. A 300-bp probe corresponding to the sequences of the
Ms0534 upstream genomic fragment of M. smegmatis was obtained by PCR
and labeled with digoxigenin dUTP (Roche). The probe was used to detect
changes in the size of the NarI-digested genomic fragment of M. smegmatis
before and after recombination. (TIFF 871 kb)
Additional file 3: Figure S3. Growth curves of M. smegmatis strains in
the absence of isoniazid. The strains are the same as those described in
Fig. 6. (TIFF 228 kb)
Additional file 4: Table S1. Strains and plasmids used in this study.
Table S2. Primers used in this study. Table S3. Primers used for
quantitative real time-PCR and reverse transcription PCR. (DOC 67 kb)
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